Clinical efficacy of concurrent chemoradiotherapy after radical hysterectomy and its impact on long-term survival prognosis in elderly patients with early-stage high-risk cervical cancer
CSTR:
Author:
Affiliation:

(1.Department of Emergency, Shanghai First Maternity and Infant Hospital, First Maternity and Infant Hospital Affiliated to Tongji University, Shanghai 201202, China;2.Intensive Care Unit, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200082, China)

Clc Number:

Fund Project:

This work was supported by Research Project of Shanghai Municipal Science and Technology Commission (20Y11907100).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the clinical efficacy of concurrent chemoradiotherapy (CCRT) after radical hysterectomy in elderly patients with early-stage high-risk cervical cancer and to analyze its impact on long-term survival prognosis. Methods A total of 130 elderly patients with early-stage high-risk cervical cancer who underwent radical hysterectomy at the First Maternity and Infant Hospital of Shanghai from January 2019 to February 2022 were enrolled as the research subjects. According to different treatment methods, they were divided into two groups (65 in each):the control group receiving sequential radiotherapy and chemotherapy (SCRT) and the observation group receiving CCRT after surgery. Radioimmunoassay was used to analyze the serum sex hormone levels. Enzyme-linked immunosorbent assay (ELISA) was used to measure thymidine kinase 1 (TKI), human epididymal protein 4 (HE4), cytokeratin 19 fragment antigen 21-1 (CYFRA21-1), tumor-specific growth factor (TSGF), carbohydrate antigen 125 (CA125), and serum squamous cell carcinoma (SCC) antigen. Survival at 1-year and 2-year follow-up was recorded. SPSS 23.0 was used for data analysis. According to the data type, t test orχ2 test was used for inter-group comparison. Results The treatment efficacy rate of the observation group was higher than that of the control group, and the difference was statistically significant (95.92% vs 86.15%; P<0.05). After treatment, the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) in the observation group were all lower than those in the control group, and the difference was statistically significant [(13.55±2.17) vs (18.64±2.59)μ/L, (11.27±2.61) vs (15.64±2.67)μ/L, (2.36±9.11) vs (124.26±15.88) pmol/L; all P<0.05]. The progesterone levels in the observation group was higher than that in the control group [(9.55±1.02) vs (7.64±0.81) nmol/L; P<0.05]. Post-treatment levels of TKI, HE4, and CYFRA21-1 in the observation group were all lower than those in the control group [(0.69±0.08) vs (1.79±0.22) pmol/L, (54.22±6.17) vs (95.44±10.23) pmol/L, (5.26±0.61) vs (8.44±0.91) μg/L; all P<0.05]. The levels of TSGF, CA125, and serum SCC in the observation group were all lower than those in the control group[(32.54±4.28) vs (47.11±5.29) U/ml, (14.23±2.54) vs (19.56±2.33) U/ml, (2.34±0.28) vs (3.65±0.39)μg/L; all P<0.05]. There were no significant differences in the 1-year and 2-year survival rates between two groups (P>0.05). Conclusion Concurrent chemoradiotherapy has significantly better short-term efficacy than sequential chemoradiotherapy after radical hysterectomy in elderly patients with early-stage high-risk cervical cancer and has less impact on sex hormone levels and more effective suppression of tumor cell proliferation and metastasis. However, long-term survival benefits warrant further investigation and verification.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 16,2024
  • Revised:
  • Adopted:
  • Online: July 23,2025
  • Published:
Article QR Code